Description: Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.
Home Page: ir.dermapharm.de
Lil-Dagover-Ring 7
Grünwald,
82031
Germany
Phone:
49 89 6 41 86 0
Officers
| Name | Title |
|---|---|
| Dr. Hans-Georg Feldmeier | CEO & Chairman of the Management Board |
| Mr. Christof Dreibholz | CFO, Chief Compliance Officer & Member of Management Board |
| Dr. Andreas Eberhorn | Chief Marketing Officer & Member of Management Board |
| Ms. Britta Hamberger | Head of Investor Relations & Corporate Communications |
Exchange: XETRA
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 16.4474 |
|---|---|
| Trailing PE: | 20.3247 |
| Price-to-Book MRQ: | 3.5051 |
| Price-to-Sales TTM: | 1.7842 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3603 |